Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03733418 · ClinicalTrials.gov registry record
Vitamin D to Improve Outcomes by Leveraging Early Treatment: Long-term Brain Outcomes in Vitamin D Deficient Patients
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 95
- Enrollment target
NCT03733418 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 95 participants.
The verdict
NCT03733418 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 95 participants
- Enrollment target
Study Summary
This ancillary study will determine if early administration of a single high-dose (540,000 IU) oral vitamin D3 (cholecalciferol) treatment improves 12-month global cognition and executive function as determined by comprehensive neuropsychological testing in 140 critically ill patients with Vitamin D deficiency at enrollment.
Interventions
- DRUG Placebo
- DRUG 540,000 IU vitamin D3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2020-02-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03733418
The ClinicalTrials.gov registry entry for NCT03733418 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03733418 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03733418 about?
NCT03733418 is a clinical study titled "Vitamin D to Improve Outcomes by Leveraging Early Treatment: Long-term Brain Outcomes in Vitamin D Deficient Patients". This ancillary study will determine if early administration of a single high-dose (540,000 IU) oral vitamin D3 (cholecalciferol) treatment improves 12-month global cognition and executive function as determined by comprehensive neuropsychological testing in 140 critically ill patients with Vitamin D...
What is the current status of trial NCT03733418?
This trial is currently completed. The enrollment target is 95 participants. The study started on 2018-11-01. Estimated completion is 2020-02-21.
What interventions are being tested in trial NCT03733418?
The interventions under investigation include: Placebo (DRUG), 540,000 IU vitamin D3 (DRUG).
Who is sponsoring clinical trial NCT03733418?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.